El dolutegravir es un medicamento nuevo, más potente, asequible, con menos posibilidades de generar resistencias y mejor tolerado, en comparación con los otros antirretrovirales disponibles.
The study demonstrates that the receptor Siglec-1 is used by different virus, such as Ebola, Marburg and HIV, to enter the myeloid cells and develops novel antibodies against this protein
The final results of the PARTNER study are now published in the leading medical journal The Lancet. The study reports zero HIV transmissions over eight years in gay men not using condoms, finally confirming that an undetectable ...
Participants de la Fundació Luita contra la Sida: Albert Tuldrà, Jordi Puig, Patricia Cobarsi, Cristina Miranda, Silvia Gel, Roser Escrig, Cristina Herrero, Núria Pérez y Cora Loste.
'Nature' reports the case of a patient who underwent a stem cell transplant for lymphoma and has been in HIV remission for 18 months despite antiretroviral therapy interruption.
The Department of Infectious Diseases of the Hospital Universitari Germans Trias i Pujol, Barcelona (Spain) is seeking an academic infectious disease physician.
Institutions on the campus held a celebratory workshop that included hearing scientific presentations; outlining of work to be done and the signing of a declaration of intentions by the directors. The event closed with a ...
0
READ